An International Randomized Study Evaluating the Efficacy and Safety of Fondaparinux Versus Control Therapy in a Broad Range of Patients With ST Segment Elevation Acute Myocardial Infarction.

Trial Profile

An International Randomized Study Evaluating the Efficacy and Safety of Fondaparinux Versus Control Therapy in a Broad Range of Patients With ST Segment Elevation Acute Myocardial Infarction.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 May 2011

At a glance

  • Drugs Fondaparinux sodium; Heparin
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms OASIS-6
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 10 May 2011 Additional lead trial centres identified as reported by ClinicalTrials.gov.
    • 10 May 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top